
Former US President Donald Trump is rumored to be considering a new executive order that would reclassify marijuana under federal law, following growing concern over a newly highlighted health condition associated with prolonged cannabis use.
Cannabis laws in the United States remain inconsistent. While recreational and medical marijuana use is legal in several states such as California, it remains illegal in others, including Texas. At the federal level, marijuana is still classified as a Schedule I substance under the Controlled Substances Act of 1970, alongside drugs such as heroin, LSD, and MDMA.
According to reports cited by ABC, Trump may sign an executive order that would move marijuana to a Schedule III classification. This change would significantly ease federal restrictions and allow expanded scientific and medical research.
Schedule I drugs are defined as having a high potential for abuse, no accepted medical use, and a lack of safety under medical supervision. In contrast, Schedule III substances are considered to have moderate to low potential for dependence and accepted medical applications.
Speaking earlier this week, Trump said reclassification could unlock extensive research opportunities. He noted that many studies cannot be conducted under the current classification and confirmed that the issue is being strongly considered.
The discussion comes amid increased attention on cannabis hyperemesis syndrome (CHS), a condition now listed by the World Health Organization in its International Classification of Diseases due to a surge in reported cases.
CHS primarily affects long-term cannabis users and is characterized by severe nausea, repeated vomiting, and a condition known as “scromiting,” which involves screaming and vomiting simultaneously.
A 23-year-old woman, Sydni Collins, shared her experience with the condition, explaining that symptoms began after years of regular cannabis use. She described daily episodes of intense vomiting that disrupted her education and daily life.
Emergency medicine specialist Dr Chris Buresh explained that CHS can develop after years of use, even in individuals who previously experienced no negative effects. He emphasized that vulnerability thresholds vary and that even small amounts of cannabis can trigger severe symptoms in some users.
Trump previously acknowledged the complexity of marijuana policy, stating that while there are recognized medical benefits, there are also serious concerns associated with recreational use. A final decision on reclassification, he said, would aim to balance public health, research needs, and regulatory clarity.
Source: Unilad






